Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Drug Resistance

  Free Subscription


04.10.2021

2 Antimicrob Agents Chemother
1 BMJ
2 J Clin Microbiol
3 J Infect Dis
2 J Med Microbiol
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. SABOUR S, Huang JY, Bhatnagar A, Gilbert SE, et al
    Detection and Characterization of Targeted Carbapenem-Resistant Healthcare-Associated Threats: Findings from The Antibiotic Resistance Laboratory Network, 2017-2019.
    Antimicrob Agents Chemother. 2021 Sep 27:AAC0110521. doi: 10.1128/AAC.01105.
    PubMed         Abstract available

  2. COX GW, Parmley EJ, Avery BP, Irwin RJ, et al
    A one health genomic investigation of gentamicin resistance in Salmonella from human and chicken sources in Canada, 2014-2017.
    Antimicrob Agents Chemother. 2021 Sep 27:AAC0096621. doi: 10.1128/AAC.00966.
    PubMed         Abstract available


    BMJ

  3. BOERE TM, van Buul LW, Hopstaken RM, van Tulder MW, et al
    Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial.
    BMJ. 2021;374:n2198.
    PubMed         Abstract available


    J Clin Microbiol

  4. BIZOT E, Cointe A, Smadja N, Sergentet D, et al
    Improved molecular diagnosis and culture of the emerging heteropathotype enterohemorrhagic Escherichia coli O80:H2 using its non-melibiose-fermenting and antibiotic-resistance properties.
    J Clin Microbiol. 2021 Sep 29:JCM0153021. doi: 10.1128/JCM.01530.
    PubMed         Abstract available

  5. ITO CAS, Bail L, Arend LNVS, Silva KO, et al
    Evaluation of Microscan WalkAway for determination of ceftazidime/avibactam and ceftolozane/tazobactam susceptibility in carbapenem-resistant Gram-negative bacilli.
    J Clin Microbiol. 2021 Sep 29:JCM0153621. doi: 10.1128/JCM.01536.
    PubMed         Abstract available


    J Infect Dis

  6. PETTIGREW MM, Tanner W, Harris AD
    The Lung Microbiome and Pneumonia.
    J Infect Dis. 2021;223.
    PubMed        

  7. GERARDIN Y, Timberlake S, Allegretti JR, Smith MB, et al
    Beyond Fecal Microbiota Transplantation: Developing Drugs from the Microbiome.
    J Infect Dis. 2021;223.
    PubMed         Abstract available

  8. DUCARMON QR, Kuijper EJ, Olle B
    Opportunities and Challenges in Development of Live Biotherapeutic Products to Fight Infections.
    J Infect Dis. 2021;223.
    PubMed         Abstract available


    J Med Microbiol

  9. CHUA TP, Bodiyabadu K, Machalek DA, Garland SM, et al
    Prevalence of Mycoplasma genitalium fluoroquinolone-resistance markers, and dual-class-resistance markers, in asymptomatic men who have sex with men.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available

  10. VILELA FP, Falcao JP
    Analysis of the antimicrobial resistance gene frequency in whole-genome sequenced Vibrio from Latin American countries.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available


    PLoS One

  11. AYENEW Z, Tigabu E, Syoum E, Ebrahim S, et al
    Multidrug resistance pattern of Acinetobacter species isolated from clinical specimens referred to the Ethiopian Public Health Institute: 2014 to 2018 trend anaylsis.
    PLoS One. 2021;16:e0250896.
    PubMed         Abstract available

  12. LEE R, Choi SM, Jo SJ, Han S, et al
    A quasi-experimental study on stethoscopes contamination with multidrug-resistant bacteria: Its role as a vehicle of transmission.
    PLoS One. 2021;16:e0250455.
    PubMed         Abstract available

  13. OLIVEIRA O, Gaio R, Correia-Neves M, Rito T, et al
    Evaluation of drug-resistant tuberculosis treatment outcome in Portugal, 2000-2016.
    PLoS One. 2021;16:e0250028.
    PubMed         Abstract available

  14. CHILAMBI GS, Nordstrom HR, Evans DR, Kowalski RP, et al
    Genomic and phenotypic diversity of Enterococcus faecalis isolated from endophthalmitis.
    PLoS One. 2021;16:e0250084.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: